ArticleChina CDC weekly2025
Changing Patterns of Epidemiological Characteristics and Spatial-Temporal Clusters of Human Brucellosis Based on County Level - China, 2011-2023.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Spatiotemporal dynamics and serosurveillance landscape of brucellosis at the human-animal interface in the Chinese Southwest: A retrospective study.PLoS neglected tropical diseases · 2026Article
- Spatiotemporal dynamics and environmental factors of human brucellosis in mainland China, 2004-2022.BMC infectious diseases · 2026Article
- Metagenomic Next-Generation Sequencing in Brucellar Spondylitis with Discordant Serologic Findings in a Non-Endemic Region: A Case Report and Literature Review.Infection and drug resistance · 2026Article
- The epidemiological characteristics of notifiable infectious diseases in a Yunnan hospital, China, 2014-2023.BMC public health · 2025Article
- Bioinformatic analysis of brucellosis and construction of a diagnostic model based on key genes.Scientific reports · 2025Article
- [Evaluation of Gradient-Variant Quantum Dot Fluorescence Technology for Rapid Detection ofSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025Article
- Protocol for a randomized controlled trial on the impact of a health action process approach model-based mobile health intervention via WeChat on health behaviors of brucellosis patients.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Human brucellosis persists as a critical public health challenge in China. Understanding disease clusters and trends is essential for implementing effective control strategies. This study evaluates the epidemiological characteristics and spatiotemporal distribution of brucellosis in China from 2011 to 2023. Methods: Data were obtained from the National Notifiable Disease Reporting System (NNDRS). We conducted descriptive epidemiological analyses and employed SaTScan10.1 and ArcGIS10.7 software to identify disease clusters and generate county (district)-level incidence maps. Results: The incidence of human brucellosis in Chinese mainland increased substantially between 2011 and 2023, rising from 38,151 cases (2.8/100,000) across 834 counties (25.4%) to 70,439 cases (5.2/100,000) across 2,290 counties (76.9%). A significant upward trend in reported incidence emerged during 2018-2023 (average annual percentage change (AAPC)=14.9%, Conclusions: The human brucellosis epidemic in China continues to intensify, characterized by rebounding incidence rates and broader geographical distribution across counties (districts). While spatiotemporal clusters remain predominantly centered in Inner Mongolia and neighboring regions, targeted interventions and increased resource allocation for high-risk areas and populations are imperative.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.